Table 3.
Prevalence of HPV in Pregnant and Non-Pregnant Women After Age Stratification. (N=2154)
| Age | Pregnant Women (n=1077) | Non-Pregnant Women (n=1077) | P value |
|---|---|---|---|
| <25 years, n=57 | |||
| HPV | 28.1% (16/57) | 14.0% (8/57) | 0.066 |
| HR-HPV | 21.1% (12/57) | 12.3% (7/57) | 0.209 |
| LR-HPV | 10.5% (6/57) | 7.0% (4/57) | 0.508 |
| Single-type infectiona | 21.1% (12/57) | 5.3% (3/57) | 0.013 |
| Multi-type infectionsb | 10.5% (6/57) | 8.8% (5/57) | 0.751 |
| 25–29 year, n=523 | |||
| HPV | 21.6% (113/523) | 16.1% (84/523) | 0.022 |
| HR-HPV | 18.7% (98/523) | 13.4% (70/523) | 0.018 |
| LR-HPV | 7.1% (37/523) | 3.6 (19/523) | 0.013 |
| Single-type infectiona | 12.2% (64/523) | 12.8% (67/523) | 0.779 |
| Multi-type infectionsb | 7.1% (37/523) | 3.3% (17/523) | 0.005 |
| 30–34 years, n=327 | |||
| HPV | 24.7% (81/327) | 14.4% (47/327) | 0.001 |
| HR-HPV | 20.8% (68/327) | 9.5% (31/327) | <0.001 |
| LR-HPV | 7.6% (25/327) | 7.0% (23/327) | 0.764 |
| Single-type infectiona | 18.0% (59/327) | 11.3% (37/327) | 0.015 |
| Multi-type infectionsb | 6.7% (22/327) | 3.1% (10/327) | 0.030 |
| ≥35 years, n=170 | |||
| HPV | 30.0% (51/170) | 11.8% (20/170) | <0.001 |
| HR-HPV | 23.5% (40/170) | 10.6% (18/170) | 0.002 |
| LR-HPV | 10.6% (18/170) | 1.8% (3/170) | 0.001 |
| Single-type infectiona | 22.9% (39/170) | 10.6% (18/170) | 0.002 |
| Multi-type infectionsb | 7.1% (12/170) | 1.2% (2/170) | 0.006 |
Notes: aSuffer from a single human papillomavirus genotype infection; bsuffer from at least two or more genotypes of human papillomavirus infection.
Abbreviations: HPV, human papillomavirus, including types HPV-6, -11, -16, -18, -31, -33, -35, -39, -42, -43, -45, -51, -52, -53, -56, -58, -59, -66, -68, -73, -81, -82, -83; HR-HPV, high-risk human papillomavirus, including types HPV-16, -18, -31, -33, -35, -39, -45, -51, -52, -56, -58, -59, -66, -68; LR-HPV, low-risk human papillomavirus, including types HPV-6, -11, -42, -43, -53, -73, -81, -82, -83.